Peter Karachunski, MD | DuchenneXchange

welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
Healthcare Providers

Peter Karachunski, MD

Healthcare Provider
Assistant Professor
Department of Neurology
University of Minnesota Medical School
420 Delaware St. SE
Minneapolis, Minnesota, United States

Dr. Karachunski is a University of Minnesota physician and an assistant professor of neurology at the University of Minnesota. He holds extensive training in clinical neurology with special expertise in pediatric neurology. He is also the Clinical Director of Paul and Sheila Wellstone Muscular Dystrophy Center at the University of Minnesota.

Dr. Karachunski specializes in “translating novel therapeutic approaches” for the treatment of different muscular dystrophies. His clinical expertise focuses on nerve and muscle pathology, neuromuscular medicine and pediatric neuromuscular disorders. His research interests include Duchene muscular dystrophy, children with myotonic dystrophy, myotonic dystrophies types 1 and 2, and pediatric fascioscapulohumerol muscular dystrophy.

Recently Dr. Karachunski was the principal investigator of a study entitled “Bone health in Duchene muscular dystrophy” and a study involving the treatment of ambulant boys with Duchene muscular dystrophy.

 

Representative Publications:

Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up

Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy

One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development

Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: A prospective cohort study

rareRelated